Relationship Status between Vancomycin Loading Dose and Treatment Failure in Patients with MRSA Bacteremia: It’s Complicated
暂无分享,去创建一个
C. Giuliano | M. Rybak | J. Pogue | E. Zasowski | Ryan P. Mynatt | Anthony M. Casapao | J. Ortwine | Claudia Hanni
[1] S. C. Forland,et al. Outcomes of Vancomycin plus a β-Lactam versus Vancomycin Only for Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia , 2017, Antimicrobial Agents and Chemotherapy.
[2] O. Slanař,et al. Importance of vancomycin loading doses in intermittent infusion regimens. , 2017, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[3] M. Rybak,et al. Identification of Vancomycin Exposure-Toxicity Thresholds in Hospitalized Patients Receiving Intravenous Vancomycin , 2017, Antimicrobial Agents and Chemotherapy.
[4] C. Giuliano,et al. Effect of vancomycin initial dosing on time to systemic inflammatory response syndrome resolution in patients with methicillin-resistant Staphylococcus aureus bacteremia , 2017, Journal of chemotherapy.
[5] Alexis Peralta,et al. Pharmacokinetic Assessment of Vancomycin Loading Dose in Critically Ill Patients , 2017, Antimicrobial Agents and Chemotherapy.
[6] V. Afreixo,et al. Evaluation of vancomycin MIC creep in methicillin-resistant Staphylococcus aureus infections-a systematic review and meta-analysis. , 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[7] C. Thomson,et al. Management of Adults with Hospital-acquired and Ventilator-associated Pneumonia. , 2016, Annals of the American Thoracic Society.
[8] Peggy Cruse,et al. Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[9] D. Levine,et al. Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections , 2016, Antimicrobial Agents and Chemotherapy.
[10] R. Arnold,et al. High Single-dose Vancomycin Loading Is Not Associated With Increased Nephrotoxicity in Emergency Department Sepsis Patients. , 2016, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[11] R. Kullar,et al. Association between Vancomycin Day 1 Exposure Profile and Outcomes among Patients with Methicillin-Resistant Staphylococcus aureus Infective Endocarditis , 2015, Antimicrobial Agents and Chemotherapy.
[12] F. Koura,et al. Pharmacokinetics of Vancomycin in Extremely Obese Patients with Suspected or Confirmed Staphylococcus aureus Infections , 2015, Pharmacotherapy.
[13] G. Drusano,et al. Vancomycin exposure in patients with methicillin-resistant Staphylococcus aureus bloodstream infections: how much is enough? , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] Roger W. Jelliffe,et al. Are Vancomycin Trough Concentrations Adequate for Optimal Dosing? , 2013, Antimicrobial Agents and Chemotherapy.
[15] Ronald N. Jones,et al. Evaluation of Vancomycin Susceptibility Testing for Methicillin-Resistant Staphylococcus aureus: Comparison of Etest and Three Automated Testing Methods , 2013, Journal of Clinical Microbiology.
[16] Anand Kumar,et al. Vancomycin pharmacodynamics and survival in patients with methicillin-resistant Staphylococcus aureus-associated septic shock. , 2013, International journal of antimicrobial agents.
[17] D. Alexander,et al. Performance of a vancomycin dosage regimen developed for obese patients. , 2012, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[18] A. Padiglione,et al. Simple approach to improving vancomycin dosing in intensive care: a standardised loading dose results in earlier therapeutic levels , 2012, Internal medicine journal.
[19] M. Boro,et al. Determining vancomycin clearance in an overweight and obese population. , 2011, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[20] Sara E Cosgrove,et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[21] G. Drusano,et al. Larger Vancomycin Doses (at Least Four Grams per Day) Are Associated with an Increased Incidence of Nephrotoxicity , 2008, Antimicrobial Agents and Chemotherapy.
[22] Á. Soriano,et al. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[23] M. Rybak,et al. Outcome Assessment of Minimizing Vancomycin Monitoring and Dosing Adjustments , 1999, Pharmacotherapy.
[24] L. Bauer,et al. Vancomycin dosing in morbidly obese patients , 1998, European Journal of Clinical Pharmacology.
[25] R. Slaughter,et al. Vancomycin Pharmacokinetics in a Patient Population: Effect of Age, Gender, and Body Weight , 1994, Therapeutic drug monitoring.
[26] R. Blouin,et al. Vancomycin pharmacokinetics in normal and morbidly obese subjects , 1982, Antimicrobial Agents and Chemotherapy.
[27] M. Zervos,et al. Comparative Effectiveness of Vancomycin Versus Daptomycin for MRSA Bacteremia With Vancomycin MIC >1 mg/L: A Multicenter Evaluation. , 2016, Clinical therapeutics.
[28] Sara E Cosgrove,et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[29] D. Levine,et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. , 2009, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.